Researchers have developed a new way to study how biochemical processes can impair the immune system’s ability to recognize ...

Company to Highlight the Role of Precision Diagnostics in Transforming Rare and Undiagnosed Disease CareHOUSTON, Aug. 25, ...

RNA-binding proteins use a dual binding mechanism involving zinc finger (ZnF) domains and intrinsically disordered regions ...

Avidity Biosciences surges 36% on reports that Novartis may eye a deal, with talks said to be early and interest from other suitors possible.

The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...

Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...

Uganda is collaborating with researchers from the United States to develop treatments for cancer and diabetes. Uganda’s President Yoweri Kaguta Museveni announced that he welcomed a team of American ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...

Cracking the Code, narrated by Mark Ruffalo, tells the inspiring story of Phil Sharp’s journey from Kentucky farm boy to Nobel laureate. His 1977 discovery of RNA splicing revolutionized molecular ...

Both public and private funding have plummeted as federal policy changes have thrown the biotech sector into an era of ...

Tuberculosis (TB) is the world's deadliest infectious disease—and one of the hardest to cure. Standard treatment requires a ...

Scientists have decoded a century-old killer hiding in a preserved lung. New genetic evidence from 1918 reveals the virus was ...